Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 May, 2018 21:29 IST
Glenmark to introduce generic Seretide Accuhaler in Denmark
Source: IRIS | 16 May, 2018, 11.59AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Europe (Glenmark) today announced that it has launched a generic version of Seretide Accuhaler in Denmark. This is Glenmark's first inhaled respiratory product launch in Europe.
 
Glenmark is the first generic company to receive regulatory approval for substitution in Denmark for its generic of Seretide Accuhaler Glenmark had entered into a strategic development & licensing agreement with Celon Pharma S.A. (Celon) to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler product-Fluticasone/Salmeterol dry powder inhaler in 15 European countries. Fluticasone/Salmeterol dry powder inhaler is a combination product for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Glenmark has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.

''Denmark is the first country in Europe where Glenmark has launched its generic Fluticasone/Salmeterol Dry powder Inhaler (DPI) and we plan to commercialize this product across the Nordics in the near future. The grant of substitution in Denmark for this complex product affirms Glenmark's capabilities in the respiratory segment,'' said Achin Gupta, Executive Vice President & Business Head of Europe and Latin America, Glenmark Pharmaceuticals.

(Q,N,C,F)*

Shares of the company gained Rs 8.25, or 1.63%, to trade at Rs 514.50. The total volume of shares traded was 11,625 at the BSE (11.46 a.m., Wednesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
Bajaj Auto quarterly net up 36.33% - 18-May-2018 15:24
3i Infotech Services forays into retail as new vertical - 18-May-2018 13:04
Shriram Transport Finance inks MoU with HPCL - 18-May-2018 12:49
Airtel, Amazon India join hands to introduce a range of affordable 4G smartphones - 18-May-2018 12:11
L&T Construction wins orders worth Rs 15.04 bn - 18-May-2018 10:12
Glenmark Pharmaceuticals updates on clinical study of GBR 830 - 18-May-2018 10:08
R-Jio, Screenz partner to provide entertainment-based interactive platform - 18-May-2018 10:03
Sun Pharma launches generic Welchol tablets in US - 18-May-2018 09:49
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer